Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Relypsa
5301 Patrick Henry Drive
Santa Clara, CA 95054
Phone: 408-200-9500
www.relypsa.com

Relypsa, Inc. is a clinical-stage pharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is patiromer, a non-absorbed potassium binder for the treatment of hyperkalemia. Relypsa is pursuing the discovery of additional product candidates through use of its proprietary polymer platform.

Key Contact
NameTitleE-Mail
Gerrit KlaernerPresident


Funding Events
DateAmountTypeInvestors
08/15/12$80,000,000Series C 5AM Ventures
Delphi Ventures
Mediphase Venture Partners
New Leaf Venture Partners
OrbiMed Advisors
Sibling Capital
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.